Skip to main content
Top

Drugs

Issue 8/2020

Content (9 Articles)

A New Paradigm for Achieving a Rapid Antidepressant Response

Gin S. Malhi, Grace Morris, Erica Bell, Amber Hamilton

Uveitis Therapy: The Corticosteroid Options

Lianna M. Valdes, Lucia Sobrin

ACE Inhibitor Benefit to Kidney and Cardiovascular Outcomes for Patients with Non-Dialysis Chronic Kidney Disease Stages 3–5: A Network Meta-Analysis of Randomised Clinical Trials

  • Open Access
  • Cough
  • Systematic Review

Yaru Zhang, Dandan He, Wei Zhang, Yue Xing, Yipeng Guo, Fuzhen Wang, Junya Jia, Tiekun Yan, Youxia Liu, Shan Lin

Tepotinib: First Approval

  • NSCLC
  • AdisInsight Report

Anthony Markham

Tirabrutinib: First Approval

Sohita Dhillon

Ozanimod: First Approval

Yvette N. Lamb

Keynote webinar | Spotlight on dry eye disease

  • Live
  • Webinar | 28-05-2026 | 13:00 (CEST)

DED is highly prevalent yet challenging to diagnose and treat. Join leading experts to explore the latest developments and gain practical guidance on effective management in busy clinical settings. Brought to you by Springer Medicine and Eye.

Watch it live: 28 May 2026, 13:00–14:00 (CEST)

Prof. Harminder Dua
Prof. Sajjad Ahmad
Prof. Anat Galor
Join the webinar
Webinar
Image Credits
Conceptual illustration of dry eye disease/© Science Photo Library / Getty Images